Science Explorer Back to mapMap
Discussion
Researcher · Hôpital de Jolimont · Belgium

André Delannoy

André Delannoy publishes mostly in Hematology, Genetics and Public Health, Environmental and Occupational Health, on topics such as Chronic Lymphocytic Leukemia Research, Acute Lymphoblastic Leukemia research and Chronic Myeloid Leukemia Treatments.

OpenAlex
World rank
#2,575,075
of 7,710,434 ranked researchers
Rank in Belgium
#23,381
of 67,186
Works
159
Citations
5.3k
Citations per work
33.5
h-index
34
i10-index 75Top 9% in Hematology
André Delannoy

What does André Delannoy research?

André Delannoy's work is mostly in Medicine (65%), Immunology and Microbiology (6%).

Health Sciences: 103 works · 64.8% of their workMedicine: 103 works · 64.8% of their workHematology: 35 works · 22.0% of their workGenetics: 27 works · 16.8% of their workPublic Health, Environmental and Occupational Health: 19 works · 12.1% of their workOncology: 12 works · 7.6% of their workPathology and Forensic Medicine: 10 works · 6.3% of their workEverything else: 46 works · 29.1% of their workLife Sciences: 10 works · 6.1% of their workImmunology and Microbiology: 10 works · 6.1% of their workImmunology: 10 works · 6.1% of their workTHEIR WORKAndré Delannoy159works
Life Sciences6%Health Sciences65%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine10364.8%
  2. Everything else4629.1%
    1. Immunology and Microbiology106.1%
  1. 1Hematology22% of their works
  2. 2Genetics17% of their works
  3. 3Public Health, Environmental and Occupational Health12% of their works
  4. 4Oncology8% of their works
  5. 5Pathology and Forensic Medicine6% of their works
  6. 6Immunology6% of their works

Research topics

Which keywords describe André Delannoy's research?

The keywords of their largest research topics: Prognostic Factors, Rituximab, Chronic Lymphocytic Leukemia, Genomic Aberrations, Acute Lymphoblastic Leukemia, Childhood Cancer, BCR-ABL and Imatinib.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Prognostic Factors1443 topics
  2. Rituximab872 topics
  3. Chronic Lymphocytic Leukemia621 topic
  4. Genomic Aberrations621 topic
  5. Acute Lymphoblastic Leukemia521 topic
  6. Childhood Cancer521 topic
  7. BCR-ABL331 topic
  8. Imatinib331 topic
  9. AML301 topic
  10. Acute Myeloid Leukemia301 topic
  11. Classification251 topic
  12. Lymphoma251 topic
  13. Genetic Mutations151 topic
  14. Primary Immunodeficiency151 topic
  15. Alloimmunization101 topic
  16. Blood Groups101 topic
  17. Platelets101 topic
  18. Thrombosis101 topic

Where does André Delannoy work?

André Delannoy's main affiliation in the publication record is Hôpital de Jolimont, Belgium.

How many publications and citations does André Delannoy have?

OpenAlex counts 159 works and 5,322 citations for André Delannoy, an h-index of 34, ranking #2,575,075 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about André Delannoy. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.